gg trend glp-1 reviews Frontiers Mayo Clinic researchers have developed

This article examines the evidence for blood pressure reduction with GLP-1 therapy, identifies which patients may benefit most from this additional effect, and outlines important safety considerations

O'Donovan, D

Kobori T, Onishi Y, Yoshida Y, et al

Psychological and Quality of Life Enhancements The psychological benefits of GLP-1 treatment are noteworthy

An FDA decision is expected in 2025

His work focuses on how microbial ecosystems interact with human physiology, including: Gut barrier function and intestinal permeability Mucus-associated microbiota (Akkermansia-related systems) Oralgut microbiome axis Short-chain fatty acids (SCFAs) and metabolic signaling Circadian rhythmmicrobiome interactions Clinical Research Contributions He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including: Active Ulcerative Colitis (Inflammatory Bowel Disease) Hyperoxaluria (Oxalate Metabolism Disorder) Microbiome-driven gut health and inflammatory conditions These studies were part of broader clinical development programs evaluating microbiome-based approaches